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work pertaining to the complex aetiology of persistent diar-
rhoea in the tropics and the challenges of differential diagnosis
[2,3]. We agree that the inclusion of asymptomatic controls in
epidemiological studies is pivotal to deepen our understanding
of the aetiology of infectious diseases, which in turn will guide
patient management and public health action. Three additional
points are offered for consideration.
First, it is important to note that the epidemiology of in-
fectious diseases varies depending on the social–ecological
context [4,5]. Hence, there is a need to carefully validate
whether insights gained in typical Western settings pertaining to
the aetiology and differential diagnosis of infectious disease
syndromes may readily be transferred to resource-constrained
settings of tropical and subtropical areas. For example, a recent
study has shown considerable variation in the pathogenesis and
antimicrobial resistance patterns of Staphylococcus aureus iso-
lates giving rise to skin and soft tissue infections (SSTIs) across
continents, and the authors have called for the development
and implementation of region-speciﬁc recommendations for an
adequate clinical management [6]. We believe that a syndrome-
speciﬁc approach to investigate common clinical problems inClinical Microbiology and Infection © 2015 European Society of Clow- and middle-income countries is more appropriate than
studies or interventions targeted at single pathogens. Apart
from SSTIs, fever of unknown origin, respiratory tract in-
fections, neurological disorders and diarrhoeal diseases are
frequently encountered in the tropics, and much needs to be
done to elucidate their aetiology and the impact on public
health in resource-constrained settings. An international
research consortium with the acronym NIDIAG (http://nidiag.
org) is currently conducting multicentric studies in Africa and
Asia to investigate the aetiology, symptomatology and clinical
management of three clinical syndromes, i.e. (i) persistent
digestive disorders (deﬁned a persistent diarrhoea 14 days in
individuals aged >12 months and/or persistent abdominal pain
in children and adolescents younger than 18 years) [2]; (ii)
persistent fever (7 days) [7]; and (iii) neurological disorders
[8]. Insights gained during these studies will be utilised to
develop evidence-based diagnosis–treatment algorithms that
will improve patient management at the peripheral healthcare
level.
Second, Dubourg and Fenollar emphasise that the setting-
speciﬁcity of infectious diseases calls for the inclusion of
healthy controls whenever the causative agents of communi-
cable diseases are studied. In our view, this suggestion is
particularly important in studies that analyse samples stemming
from body compartments that are not normally sterile, as, for
example, the gastrointestinal and the respiratory tract, and for
conditions that cannot be reliably diagnosed by well-validated
and speciﬁc tests. With regard to the aforementioned
NIDIAG study on persistent digestive disorders [2], we have
adopted a case–control approach. Case–control studies are
less suitable than cohort studies to investigate causal re-
lationships and are more prone to bias, but they nevertheless
provide relevant scientiﬁc information on the association of
certain pathogens with speciﬁc clinical symptoms [9]. In the
case of digestive disorders, our recent study from Côte
d’Ivoire has brought to light that no clear link exists between
most pathogens and the symptomatology of the infected indi-
vidual and that multiple coinfections are the norm rather than
the exception [3]. Future work should therefore not only
focus on the assessment of a range of speciﬁc pathogens, but
should also address more general perturbations of the intes-
tinal microbiome. A recent study aimed to identify all bacterial
and fungal microorganisms that could be cultured from faecal
samples stemming from 347 individuals with or without diar-
rhoea in Senegal [10]. Strikingly, the number of detected bac-
terial species was signiﬁcantly lower in individuals with
diarrhoea, a ﬁnding that could partially be explained by a
decrease of commensal species that form part of the ‘normal’
intestinal gut ﬂora. It is likely that the application of newClin Microbiol Infect 2015; 21: e53–e54
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will further our understanding of the complex pathogenesis of
digestive diseases.
Third, the routine use of molecular techniques such as po-
lymerase chain reaction (PCR) assays in epidemiological studies
investigating diarrhoeal diseases has generated unexpected and
surprising results. For decades, several pathogens such as
Shigella spp. were thought to be obligate pathogens, meaning
that no asymptomatic colonisation would occur. However,
through the application of highly sensitive stool-based multiplex
PCR, we have now learned that a considerable proportion of
healthy individuals may also be diagnosed with these organisms,
particularly in settings of high endemicity. Prompted by this
observation in PCR-based studies, Frickmann et al. [11] have
raised the question, ‘What does a positive signal tell us?’ Thus
far, no deﬁnite answer can be given, but it is likely that both
asymptomatic colonisation and prolonged shedding of pathogen
nucleic acids (e.g. after a resolved infection) contribute to the
high rates of detected pathogens in PCR-based studies.
Comprehensive comparative studies that concurrently use
highly sensitive PCR tests, bacterial stool culture, parasite mi-
croscopy and immunological rapid diagnostic tests may help to
develop standards for the clinical interpretation of PCR-positive
tests in endemic settings.
Taken together, and in view of our own data and recent
experience, we agree with the proposal made by Dubourg and
Fenollar that the uncharted epidemiology of many infectious
diseases in tropical settings calls for the inclusion of asymp-
tomatic controls. Furthermore, it is likely that the imple-
mentation of new, highly sensitive molecular diagnostics will
further improve our understanding of the pathogenesis of
important clinical syndromes in resource-constrained settings.
We hope that this knowledge can be translated into simple,
setting-speciﬁc clinical–diagnostic algorithms, such as those
being developed by the NIDIAG consortium.Transparency declarationThis work is part of the NIDIAG European research network
(Collaborative Project), supported by the European Union’sClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectSeventh Framework Programme for research, technological
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